Navigation Links
Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R)
Date:5/16/2008

Kenneth F. Binmoeller, M.D., Interventional Endoscopy Services,

California Pacific Medical Center, San Francisco, CA, and principal

investigator in the SpyGlass registry, will present results on a subset

of patients with indeterminate biliary strictures or filling defects

that underwent ERC followed by PO using the SpyGlass System and the

SpyBite(R) Biopsy Forceps. The lead author of the analysis is Douglas

Pleskow, M.D., Division of Gastroenterology, Beth Israel Deaconess

Medical Center, Boston, MA, and principal investigator in the SpyGlass

registry. The presentation will take place at 5:00 p.m. in Room 1 at

the San Diego Convention Center.

The SpyGlass Direct Visualization System will be available for demonstrations at Boston Scientific's booth #3314. The Company will also offer hands-on demonstration sessions in its Simulated Clinical Endoscopy Suite for the following products: WallFlex(R) Stents, Polyflex(R) Esophageal Stents, Radial Jaw(R) 4 Biopsy Forceps, Resolution(R) Clip, CRE(TM) Balloon Dilators and the RX Biliary System(TM).

About Digestive Disease Week(R)

DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases, the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 17-22, 2008, at the San Diego Convention Center, San Diego, CA. The meeting showcases approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. For more information, visit http://www.ddw.org.

About Boston Scientific

Boston Scientific is a worldwide de
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
2. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
3. WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
4. Fraunhofer and Boston University Hosted Prestigious SME Tour
5. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
6. Boston Scientific Announces Results for First Quarter Ended March 31, 2008
7. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
8. Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
9. Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement
10. Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology
11. Boston Scientific Announces Japanese Approval of Heart Failure Lead
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... As the R&D sector becomes increasingly ... industry to deliver better products, faster. Collaborations between ... often means turning big ideas into reality, within ... with Sensidose AB and Recipharm, is one example ... market sooner. The partnership resulted in the development ...
(Date:5/21/2013)...  MacroGenics, Inc. today announced that an abstract ... Fc-modified chimeric monoclonal antibody (MAb), in patients with ... be presented at the 2013 Annual Meeting of ... Developmental Therapeutics - Immunotherapy Oral Abstract Session on ... The presentation will describe the results of a ...
(Date:5/21/2013)... May 21, 2013 Bed bugs have become ... My Cleaning Products, many turn to chemical-based pesticides for help ... health and environmental risks those solutions present, the company advised ... Bug Bully instead. , According to My Cleaning Products, ... they used to be. It shared that the pests have ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3
... , , , PRINCETON, ... Company) (OTC Bulletin Board: DORB), a late-stage biopharmaceutical company, announced ... Officer, will present at the Rodman & Renshaw 11th Annual ... at 4:55 PM on Thursday, September 10, 2009 in the ...
... - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that ... , , - Rodman & Renshaw 11th ... September 10, 2009 at 12:30 p.m. Eastern Time in the Fahnestock Salon, ... Hotel in New York City., - Thomas ...
... 2 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Robert W. Baird & Co. 2009 Health Care Conference ... 2009 Health Care Conference in New York, New York, on September 9, 2009 ... Thomas Weisel Partners Healthcare Conference , Subsequently, Onyx will ...
Cached Biology Technology:DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 2DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 3DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 4OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences 2Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences 2
(Date:5/21/2013)... infections occur in the body, stem cells in ... and differentiating into mature immune cells that can ... can deplete these cell populations, potentially leading to ... cancer. Now, a team of researchers led by ... has found that, in mouse models, the molecule ...
(Date:5/21/2013)... and health stores, phosphatidylserine is a natural food ... to improve cognition and slow memory loss, it,s ... impairment. Now a team headed by Prof. Gil ... University,s Department of Human Molecular Genetics ... functioning of genes involved in degenerative brain disorders, ...
(Date:5/21/2013)... of biomass experts , Where? Copenhagen, ... 03-07 June 2013 , Why? ... assessment, market and policy developments, manufacturing and installation, drawing ... benefiting from its 2013 edition from a record of ... countries, more than 240 plenary and oral presentations, more ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4
... the International Osteoporosis Foundation (IOF) in its 2009 publication, ... more than 50% of all osteoporotic fractures will occur ... there is a growing need for advanced clinical training ... epidemiology and specificities of osteoporosis and related bone disorders ...
... research could eventually lead to new approaches for controlling ... which are caused by trypanosomes carried by the bloodsucking ... reproduction evolved very early and is now ubiquitous in ... living organisms except bacteria). However, real evidence is ...
... of mucus associated with chronic bronchitis, according to a ... indicates cigarette smoke suppresses a protein that causes the ... bronchitis patients. The findings were published online ahead ... American Journal of Respiratory and Critical Care Medicine ...
Cached Biology News:Shining a light on trypanosome reproduction 2Cigarette smoking increases production of mucus in patients with bronchitis 2Cigarette smoking increases production of mucus in patients with bronchitis 3
... We deliversoluble protein or No Charge ... the best soluble protein results , 24 ... submitted , Powerful results on your most ... Optimization Service (SOS) uses proprietary tools and ...
... for proteomic scale kinase profiling, quantitative ... drug discovery research built on the ... synthesis platform. These microarrays are available ... Kinase Substrate - Peptide Microarray Service. ...
... immunological studies, vaccine development, and biosensor ... powerful Paraflo microfluidic on-chip synthesis platform. ... of our comprehensive Epitope Peptide Microarray ... Probe content is completely customer ...
... Introducing our Regulatory Edition of Molecular ... imaging systems for life science research and ... supports compliance with U.S. Food and Drug ... Part 11 Electronic Records; Electronic Signatures [21 ...
Biology Products: